Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Stroke

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.108.517128PMID 18723424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD36 and macrophages in atherosclerosis.

  2007cited by this paper
• Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

  2007cited by this paper
• Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization

  2007cited by this paper
• Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity.

  2007cited by this paper
• Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma: A Novel Marker of Insulin Resistance

  2006cited by this paper
• Inflammation and cardiovascular disease mechanisms.

  2006cited by this paper
• Endothelial scavenger receptors.

  2006cited by this paper
• Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading--cDNA and protein array study.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Apoptotic cell death in atherosclerosis

  2003cited by this paper
• Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.

  2003cited by this paper
• Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation.

  2001cited by this paper
• Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

  2000cited by this paper
• CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta.

  1999cited by this paper

• More Than a Cleanup Crew: The Expanding Biology of Efferocytosis.

  2025cites this paper
• Association between CD36 and ischemic stroke: consequential or coincidental?

  2025cites this paper
• CD36 and Its Role in Obesity

  2025cites this paper
• Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype.

  2024cites this paper
• Advancing stroke recovery: unlocking the potential of cellular dynamics in stroke recovery

  2024cites this paper
• Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review

  2024cites this paper
• Is the suppression of CD36 a promising way for atherosclerosis therapy?

  2023cites this paper
• The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target

  2023cites this paper
• Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis

  2023cites this paper
• CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

  2022cites this paper
• Identification Markers of Carotid Vulnerable Plaques: An Update

  2022cites this paper
• CD36 down regulation by the macrophage antioxidant 7,8-dihydroneopterin through modulation of PPAR-γ activity

  2022cites this paper
• Biology of macrophage fate decision: Implication in inflammatory disorders

  2022cites this paper
• Genetic variants, gene expression, and soluble CD36 analysis in acute coronary syndrome: Differential protein concentration between ST‐segment elevation myocardial infarction and unstable angina

  2022cites this paper
• Non-stenotic Carotid Plaques in Embolic Stroke of Unknown Source

  2021cites this paper
• Comprehensive analysis of dysregulated genes associated with atherosclerotic plaque destabilization

  2021cites this paper
• Circulating CD36 is increased in hyperlipidemic mice: cellular sources and triggers of release.

  2021cites this paper
• Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools

  2021cites this paper
• Dietary fatty acids and CD36-mediated cholesterol homeostasis: potential mechanisms

  2020cites this paper
• Using serum biomarkers for identifying unstable carotid plaque: update of current evidence.

  2020cites this paper
• Biomarkers in Vascular Disease

  2020cites this paper
• Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability

  2020cites this paper
• Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

  2020cites this paper
• Inflammation of carotid plaques and risk of cerebrovascular events

  2020cites this paper
• The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus

  2020cites this paper
• The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond

  2020cites this paper
• Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

  2019cites this paper
• Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-metabolic complications

  2019cites this paper
• Lymphocytes upregulate CD36 in adipose tissue and liver

  2019cites this paper
• Associations of plasma CD36 and body fat distribution.

  2019cites this paper
• Oral fatty acid taste sensitivity in healthy young individuals of both sexes is related to body mass index and soluble cd36 serum levels.

  2019cites this paper
• Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects

  2019cites this paper
• Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis

  2018cites this paper
• CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis

  2018cites this paper
• Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women.

  2018cites this paper
• Assessment of potential biomarkers of atherosclerosis in Indian patients with type 2 diabetes mellitus

  2018cites this paper
• The relationship between habitual dietary sodium intake and RAAS blockade on circulating microparticle levels in type two diabetes.

  2018cites this paper
• Significant limitations associated with the analysis of human plasma soluble CD 36 performed by ELISA Analiza osoczowych stężeń CD 36 metodą ELISA oraz jej ograniczenia

  2018cites this paper
• CD36 and lipid metabolism in the evolution of atherosclerosis

  2018cites this paper
• CD36 in chronic kidney disease: novel insights and therapeutic opportunities

  2017cites this paper
• Platelet oxidative stress as a novel target of cardiovascular risk in frail older people.

  2017cites this paper
• A ROLE OF MACROPHAGES: AN OVERVIEW

  2017cites this paper
• Research Progress on the Risk Factors and Outcomes of Human Carotid Atherosclerotic Plaques

  2017cites this paper
• Maturity onset diabetes of the young: novel insights into the diagnosis, optimal treatment and clinical progression of the condition using biomarkers and new technology.

  2016cites this paper
• Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.

  2016cites this paper
• Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children

  2016cites this paper
• Unstable carotid artery plaque: new insights and controversies in diagnostics and treatment

  2016cites this paper
• Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes

  2016cites this paper
• Ultrasound and Biochemical Diagnostic Tools for the Characterization of Vulnerable Carotid Atherosclerotic Plaque.

  2016cites this paper
• Is plasma-soluble CD36 associated with density of atheromatous plaque and ankle-brachial index in early-onset coronary artery disease patients?

  2016cites this paper
• Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects.

  2016cites this paper
• Is plasma-soluble CD36 associated with density of atheromatous plaque and ankle–brachial index in early-onset coronary artery disease patients?

  2016cites this paper
• Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.

  2015cites this paper
• Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?

  2015cites this paper
• Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis

  2015cites this paper
• Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: A new potential biomarker for atherosclerosis.

  2015cites this paper
• Macrophage Polarization in Inflammatory Diseases

  2014cites this paper
• Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals

  2014cites this paper
• Relationship Between Plaque Echogenicity and Atherosclerosis Biomarkers

  2014cites this paper
• Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques

  2014cites this paper
• Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the development of THP-1 derived foam cells.

  2014cites this paper
• Caracterización del papel de la ácido graso translocasa CD36 en la enfermedad hepática grasa no alcohólica y en la hepatitis crónica por virus C

  2014cites this paper
• Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease

  2014cites this paper
• Atheroprotective effect of dietary walnut intake in ApoE-deficient mice: involvement of lipids and coagulation factors.

  2013cites this paper
• The origin of circulating CD36 in type 2 diabetes

  2013cites this paper
• Circulating CD36 Is Reduced in HNF1A-MODY Carriers

  2013cites this paper
• Biogenesis of plasma CD36+microparticles in human diabetes and the metabolic syndrome

  2013influential citation
• N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients.

  2013cites this paper
• The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

  2013cites this paper
• High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C

  2013cites this paper
• Macrophage ADAM17 Deficiency Augments CD36-Dependent Apoptotic Cell Uptake and the Linked Anti-Inflammatory Phenotype

  2013cites this paper
• Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease

  2013cites this paper
• Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease

  2013cites this paper
• Macrophage subtypes in symptomatic carotid artery and femoral artery plaques.

  2012cites this paper
• Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasma

  2012cites this paper
• Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

  2012cites this paper
• CD36 gene is associated with thickness of atheromatous plaque and ankle-brachial index in patients with early coronary artery disease.

  2012cites this paper
• CD36 Protein Is Involved in Store-operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2*

  2011cites this paper
• Microenviromental factors controlling macrophage polarization in atherosclerosis

  2011cites this paper
• Microenviromental factors controlling macrophage polarization in

  2011cites this paper
• Soluble CD36− a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?

  2011cites this paper
• A glimpse on the phenomenon of macrophage polarization during atherosclerosis.

  2011cites this paper
• Genetics of Hypertension and Cardiovascular Disease

  2011cites this paper
• The putative diabetic plasma marker, soluble CD36, is non‐cleaved, non‐soluble and entirely associated with microparticles

  2011cites this paper
• Carotid Plaque Age Is a Feature of Plaque Stability Inversely Related to Levels of Plasma Insulin

  2011cites this paper
• Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors

  2011cites this paper
• An Imbalance Between CD36 and ABCA1 Protein Expression Favors Lipid Accumulation in Stroke-Prone Ulcerated Carotid Plaques

  2010cites this paper
• Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine Inflammation in Peripheral Artery Disease

  2010cites this paper
• Blood biomarkers to identify ischemic stroke etiologies

  2010cites this paper
• Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease

  2010cites this paper
• Discovery of Antagonists for Human Scavenger Receptor CD36 via an ELISA-Like High-Throughput Screening Assay

  2010cites this paper
• Carotid plaque formation and serum biomarkers.

  2010cites this paper
• PROFILING OF HUMAN ATHEROSCLEROSIS

  2009cites this paper
• Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation.

  2009cites this paper
• The Pattern Recognition Receptor CD36 Is a Chondrocyte Hypertrophy Marker Associated with Suppression of Catabolic Responses and Promotion of Repair Responses to Inflammatory Stimuli 1

  2009cites this paper
• Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation Patologia carotidea e Ictus in pazienti con arteriopatia ostruttiva periferica. Il ruolo della infiammazione

  2009cites this paper
• [Carotis stenosis-open surgery and endovascular treatment].

  2009cites this paper
• La placca carotidea instabile nell’indicazione alla chirurgia

  2008cites this paper